companydata.dkcompanydata.dk

PHARMA NORD ApS: Financial statements 2018

CVR: 67303016

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

PHARMA NORD ApS (CVR 67303016) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 333,989,000 and a net result of DKK 37,712,000 compared with DKK 46,790,000 the year before. That is a decrease of 2.6% compared with the year before. The profit margin was 11.3%. Equity in the 2018 report amounted to DKK 212,710,000. The solvency ratio was 59.6%. The company had 364 employees in the financial year.

Revenue
DKK 333,989,000
Gross Profit
DKK 132,298,000
Profit/Loss
DKK 37,712,000
Equity
DKK 212,710,000
Total Assets
DKK 356,840,000
Employees
364

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018334 mio.132.3 mio.37.7 mio.212.7 mio.364
2017343.1 mio.135.4 mio.46.8 mio.181.9 mio.378
2016337.3 mio.149.4 mio.62 mio.142 mio.315
2015417.5 mio.198.7 mio.55.8 mio.-307
2014317.1 mio.121.5 mio.30.2 mio.29.8 mio.285

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

PHARMCO I ApS registered as owner of PHARMA NORD ApSOct 12, 2018

As of October 12, 2018, PHARMCO I ApS is registered as an owner of PHARMA NORD ApS with an ownership share of 50%.

PHARMA NORD ApS: The 2017 annual report is outJun 5, 2018

PHARMA NORD ApS has published its annual report for 2017. Revenue came to DKK 343,074,000, and the net result was DKK 46,790,000.

About PHARMA NORD ApS

PHARMA NORD ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 1981. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named DANMARKS HELSEKOST DISTRIBUTION ApS. The management consists of Eli Wallin. The board consists of Michael Christiani Havemann (chair) and Eli Wallin. The company is owned by PHARMCO I ApS and PharmCo III ApS. The company has 298 employees (2026). In 2025, the company reported revenue of DKK 518,005,000 and a net result of DKK 26,711,000 compared with DKK 32,254,000 the year before. Equity in the 2025 report amounted to DKK 181,417,000.

Source: annual report 2025, Danish Business Authority